Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Denardo

Showing results (61-70 of 274) with videos related to

Pageof 28
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Radiolabeled anti-lymphoma antibodiesG L DeNardo, R T O'Donnell, S J DeNardo
The New England Journal of Medicine|October 1, 1970
Cerebrospinal-fluid dynamicsR A Castellino, L M Zatz, G L DeNardo
Frontiers of Radiation Therapy and Oncology|January 1, 1990
A treatment planning program for radioimmunotherapyD J Macey, G L DeNardo, S J DeNardo
Cancer Research|March 1, 1972
Blood flow in irradiated mouse sarcoma as determined by the clearance of xenon-133R F Kallman, G L DeNardo, M J Stasch
Radiology|October 1, 1971
Localization of strontium 85 in soft tissue infected by Aspergillus nigerG R Ray, G L DeNardo, G H King
The American Journal of Medicine|March 1, 1972
Evaluation of the liver and spleen in Hodgkin's disease. I. The value of hepatic scintigraphyM J Lipton, G L DeNardo, S Silverman, et al.
The American Journal of Medicine|March 1, 1972
Evaluation of the liver and spleen in Hodgkin's disease. II. The value of splenic scintigraphyS Silverman, G l DeNardo, E Glatstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2003
Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapyChristine L Hartmann Siantar, Gerald L DeNardo, Sally J DeNardo
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Implantation of different malignant human cell lines in an athymic mouse does not alter success and growth rates of either xenograftLaird Miers, Sally J DeNardo, Kathleen Lamborn, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategyGerald L DeNardo, Christine L Hartmann Siantar, Sally J DeNardo
Pageof 28

Showing results (61-70 of 274) with videos related to

Sort By:
Pageof 28
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Radiolabeled anti-lymphoma antibodiesG L DeNardo, R T O'Donnell, S J DeNardo
The New England Journal of Medicine|October 1, 1970
Cerebrospinal-fluid dynamicsR A Castellino, L M Zatz, G L DeNardo
Frontiers of Radiation Therapy and Oncology|January 1, 1990
A treatment planning program for radioimmunotherapyD J Macey, G L DeNardo, S J DeNardo
Cancer Research|March 1, 1972
Blood flow in irradiated mouse sarcoma as determined by the clearance of xenon-133R F Kallman, G L DeNardo, M J Stasch
Radiology|October 1, 1971
Localization of strontium 85 in soft tissue infected by Aspergillus nigerG R Ray, G L DeNardo, G H King
The American Journal of Medicine|March 1, 1972
Evaluation of the liver and spleen in Hodgkin's disease. I. The value of hepatic scintigraphyM J Lipton, G L DeNardo, S Silverman, et al.
The American Journal of Medicine|March 1, 1972
Evaluation of the liver and spleen in Hodgkin's disease. II. The value of splenic scintigraphyS Silverman, G l DeNardo, E Glatstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2003
Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapyChristine L Hartmann Siantar, Gerald L DeNardo, Sally J DeNardo
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Implantation of different malignant human cell lines in an athymic mouse does not alter success and growth rates of either xenograftLaird Miers, Sally J DeNardo, Kathleen Lamborn, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategyGerald L DeNardo, Christine L Hartmann Siantar, Sally J DeNardo
Pageof 28